{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "20921334", "DateCompleted": {"Year": "2011", "Month": "06", "Day": "21"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "20"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1194/jlr.M006775"], "ArticleDate": [{"Year": "2010", "Month": "10", "Day": "04"}], "Journal": {"ISSN": "1539-7262", "JournalIssue": {"Volume": "52", "Issue": "1", "PubDate": {"Year": "2011", "Month": "Jan"}}, "Title": "Journal of lipid research", "ISOAbbreviation": "J Lipid Res"}, "ArticleTitle": "Formation of cholesterol ozonolysis products in vitro and in vivo through a myeloperoxidase-dependent pathway.", "Pagination": {"StartPage": "87", "EndPage": "97", "MedlinePgn": "87-97"}, "Abstract": {"AbstractText": ["3\u03b2-Hydroxy-5-oxo-5,6-secocholestan-6-al (secosterol-A) and its aldolization product 3\u03b2-hydroxy-5\u03b2-hydroxy-B-norcholestane-6\u03b2-carboxaldehyde (secosterol-B) were recently detected in human atherosclerotic tissues and brain specimens, and they may play pivotal roles in the pathogenesis of atherosclerosis and neurodegenerative diseases. However, as their origin remains unidentified, we examined the formation mechanism, the stability, and the fate of secosterols in vitro and in vivo. About 40% of secosterol-A remained unchanged after 3 h incubation in the FBS-free medium, whereas 20% and 40% were converted to its aldehyde-oxidation product, 3\u03b2-hydroxy-5-oxo-secocholestan-6-oic acid, and secosterol-B, respectively. In the presence of FBS, almost all secosterol-A was converted immediately to these compounds. Secosterol-B in the medium, with and without FBS, was relatively stable, but \u223c30% was converted to its aldehyde-oxidation product, 3\u03b2-hydroxy-5\u03b2-hydroxy-B-norcholestane-6-oic acid (secoB-COOH). When neutrophil-like differentiated human leukemia HL-60 (nHL-60) cells activated with PMA were cultured in the FBS-free medium containing cholesterol, significantly increased levels of secosterol-A and its aldehyde-oxidation product, but not secosterol-B, were formed. This secosterol-A formation was decreased in the culture of PMA-activated nHL-60 cells containing several reactive oxygen species (ROS) inhibitors and scavengers or in the culture of PMA-activated neutrophils isolated from myeloperoxidase (MPO)-deficient mice. Our results demonstrate that secoterol-A is formed by an ozone-like oxidant generated with PMA-activated neutrophils through the MPO-dependent mechanism."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Biochemistry, Graduate School of Nutritional and Environmental Sciences, University of Shizuoka, Shizuoka, Japan."}], "Identifier": [], "LastName": "Tomono", "ForeName": "Susumu", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Miyoshi", "ForeName": "Noriyuki", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Shiokawa", "ForeName": "Hidemi", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Iwabuchi", "ForeName": "Tomoe", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Aratani", "ForeName": "Yasuaki", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Higashi", "ForeName": "Tatsuya", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Nukaya", "ForeName": "Haruo", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ohshima", "ForeName": "Hiroshi", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Lipid Res", "NlmUniqueID": "0376606", "ISSNLinking": "0022-2275"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "3-hydroxy-5-hydroxy-B-norcholestane-6-carboxaldehyde"}, {"RegistryNumber": "0", "NameOfSubstance": "Cholestanones"}, {"RegistryNumber": "0", "NameOfSubstance": "Norsteroids"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "0", "NameOfSubstance": "Secosteroids"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "81811-27-0", "NameOfSubstance": "3-hydroxy-5-oxo-5,6-secocholestan-6-al"}, {"RegistryNumber": "8M308U816E", "NameOfSubstance": "Cholestanol"}, {"RegistryNumber": "97C5T2UQ7J", "NameOfSubstance": "Cholesterol"}, {"RegistryNumber": "EC 1.11.1.7", "NameOfSubstance": "Peroxidase"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Cell Differentiation"}, {"QualifierName": ["analogs & derivatives", "metabolism"], "DescriptorName": "Cholestanol"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cholestanones"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cholesterol"}, {"QualifierName": [], "DescriptorName": "HL-60 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": ["metabolism"], "DescriptorName": "Neutrophils"}, {"QualifierName": ["metabolism"], "DescriptorName": "Norsteroids"}, {"QualifierName": [], "DescriptorName": "Oxidation-Reduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "Ozone"}, {"QualifierName": ["metabolism"], "DescriptorName": "Peroxidase"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["metabolism"], "DescriptorName": "Secosteroids"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Babior B. M., Takeuchi C., Ruedi J., Gutierrez A., Wentworth P. J. 2003. Investigating antibody-catalyzed ozone generation by human neutrophils. Proc. Natl. Acad. Sci. USA. 100: 3031\u20133034.", "ArticleIdList": ["PMC152239", "12601145"]}, {"Citation": "Nieva J., Wentworth P. J. 2004. The antibody-catalyzed water oxidation pathway\u2013a new chemical arm to immune defense? Trends Biochem. Sci. 29: 274\u2013278.", "ArticleIdList": ["15130564"]}, {"Citation": "Yamashita K., Miyoshi T., Arai T., Endo N., Itoh H., Makino K., Mizugishi K., Uchiyama T., Sasada M. 2008. Ozone production by amino acids contributes to killing of bacteria. Proc. Natl. Acad. Sci. USA. 105: 16912\u201316917.", "ArticleIdList": ["PMC2579352", "18971328"]}, {"Citation": "Kettle A. J., Clark B. M., Winterbourn C. C. 2004. Superoxide converts indigo carmine to isatin sulfonic acid: implications for the hypothesis that neutrophils produce ozone. J. Biol. Chem. 279: 18521\u201318525.", "ArticleIdList": ["14978029"]}, {"Citation": "Kettle A. J., Winterbourn C. C. 2005. Do neutrophils produce ozone? An appraisal of current evidence. Biofactors. 24: 41\u201345.", "ArticleIdList": ["16403962"]}, {"Citation": "Gumulka J., Smith L. L. 1983. Ozonization of cholesterol. J. Am. Chem. Soc. 105: 1972\u20131979."}, {"Citation": "Jaworski K., Smith L. L. 1988. Ozonization of cholesterol in nonparticipating solvents. J. Org. Chem. 53: 545\u2013554."}, {"Citation": "Paryzek Z., Martynow J., Swoboda W. 1990. The reaction of cholesterol with ozone and alcohols: a revised mechanism and structure of the principal product. J. Chem. Soc., Perkin Trans. 1: 1222\u20131223."}, {"Citation": "Wentworth A. D., Song B. D., Nieva J., Shafton A., Tripurenani S., Wentworth P., Jr 2009. The ratio of cholesterol 5,6-secosterols formed from ozone and singlet oxygen offers insight into the oxidation of cholesterol in vivo. Chem. Commun. (Camb.) (21): 3098\u20133100.", "ArticleIdList": ["PMC2819220", "19462099"]}, {"Citation": "Wentworth P., Jr., Nieva J., Takeuchi C., Galve R., Wentworth A. D., Dilley R. B., DeLaria G. A., Saven A., Babior B. M., Janda K. D., et al. 2003. Evidence for ozone formation in human atherosclerotic arteries. Science. 302: 1053\u20131056.", "ArticleIdList": ["14605372"]}, {"Citation": "Zhang Q., Powers E. T., Nieva J., Huff M. E., Dendle M. A., Bieschke J., Glabe C. G., Eschenmoser A., Wentworth P. J., Lerner R. A., et al. 2004. Metabolite-initiated protein misfolding may trigger Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 101: 4752\u20134757.", "ArticleIdList": ["PMC387320", "15034169"]}, {"Citation": "Bosco D. A., Fowler D. M., Zhang Q., Nieva J., Powers E. T., Wentworth P. J., Lerner R. A., Kelly J. W. 2006. Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization. Nat. Chem. Biol. 2: 249\u2013253.", "ArticleIdList": ["16565714"]}, {"Citation": "Brinkhorst J., Nara S. J., Pratt D. A. 2008. Hock cleavage of cholesterol 5alpha-hydroperoxide: an ozone-free pathway to the cholesterol ozonolysis products identified in arterial plaque and brain tissue. J. Am. Chem. Soc. 130: 12224\u201312225.", "ArticleIdList": ["18722442"]}, {"Citation": "Uemi M., Ronsein G. E., Miyamoto S., Medeiros M. H. G., Di Mascio P. 2009. Generation of cholesterol carboxyaldehyde by the reaction of singlet molecular oxygen [O2 (1Delta(g))] as well as ozone with cholesterol. Chem. Res. Toxicol. 22: 875\u2013884.", "ArticleIdList": ["19358613"]}, {"Citation": "Tomono S., Miyoshi N., Sato K., Ohba Y., Ohshima H. 2009. Formation of cholesterol ozonolysis products through an ozone-free mechanism mediated by the myeloperoxidase-H2O2-chloride system. Biochem. Biophys. Res. Commun. 383: 222\u2013227.", "ArticleIdList": ["19345674"]}, {"Citation": "Bieschke J., Zhang Q., Powers E. T., Lerner R. A., Kelly J. W. 2005. Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation. Biochemistry. 44: 4977\u20134983.", "ArticleIdList": ["15794636"]}, {"Citation": "Bieschke J., Zhang Q., Bosco D. A., Lerner R. A., Powers E. T., Wentworth P. J., Kelly J. W. 2006. Small molecule oxidation products trigger disease-associated protein misfolding. Acc. Chem. Res. 39: 611\u2013619.", "ArticleIdList": ["16981677"]}, {"Citation": "Spillantini M. G., Goedert M. 2000. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Ann. N. Y. Acad. Sci. 920: 16\u201327.", "ArticleIdList": ["11193145"]}, {"Citation": "Sathishkumar K., Murthy S. N., Uppu R. M. 2007. Cytotoxic effects of oxysterols produced during ozonolysis of cholesterol in murine GT1\u20137 hypothalamic neurons. Free Radic. Res. 41: 82\u201388.", "ArticleIdList": ["17164181"]}, {"Citation": "Sathishkumar K., Haque M., Perumal T. E., Francis J., Uppu R. M. 2005. A major ozonation product of cholesterol, 3beta-hydroxy-5-oxo-5,6-secocholestan-6-al, induces apoptosis in H9c2 cardiomyoblasts. FEBS Lett. 579: 6444\u20136450.", "ArticleIdList": ["16288747"]}, {"Citation": "Collins S. J., Ruscetti F. W., Gallagher R. E., Gallo R. C. 1978. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc. Natl. Acad. Sci. USA. 75: 2458\u20132462.", "ArticleIdList": ["PMC392573", "276884"]}, {"Citation": "Aratani Y., Koyama H., Nyui S., Suzuki K., Kura F., Maeda N. 1999. Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect. Immun. 67: 1828\u20131836.", "ArticleIdList": ["PMC96534", "10085024"]}, {"Citation": "Higashi T., Ichikawa T., Inagaki S., Min J. Z., Fukushima T., Toyo'oka T. 2010. Simple and practical derivatization procedure for enhanced detection of carboxylic acids in liquid chromatography-electrospray ionization-tandem mass spectrometry. J. Pharm. Biomed. Anal. 52: 809\u2013818.", "ArticleIdList": ["20376914"]}, {"Citation": "Stewart C. R., Wilson L. M., Zhang Q., Pham C. L., Waddington L. J., Staples M. K., Stapleton D., Kelly J. W., Howlett G. J. 2007. Oxidized cholesterol metabolites found in human atherosclerotic lesions promote apolipoprotein C\u2013II amyloid fibril formation. Biochemistry. 46: 5552\u20135561.", "ArticleIdList": ["17429947"]}, {"Citation": "Bjorkhem I., Andersson O., Diczfalusy U., Sevastik B., Xiu R. J., Duan C., Lund E. 1994. Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc. Natl. Acad. Sci. USA. 91: 8592\u20138596.", "ArticleIdList": ["PMC44652", "8078928"]}, {"Citation": "Salonen J. T., Nyyssonen K., Salonen R., Porkkala-Sarataho E., Tuomainen T. P., Diczfalusy U., Bjorkhem I. 1997. Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation. 95: 840\u2013845.", "ArticleIdList": ["9054740"]}, {"Citation": "Brown A. J., Jessup W. 1999. Oxysterols and atherosclerosis. Atherosclerosis. 142: 1\u201328.", "ArticleIdList": ["9920502"]}, {"Citation": "Larsson D. A., Baird S., Nyhalah J. D., Yuan X-M., Li W. 2006. Oxysterol mixtures, in atheroma-relevant proportions, display synergistic and proapoptotic effects. Free Radic. Biol. Med. 41: 902\u2013910.", "ArticleIdList": ["16934673"]}, {"Citation": "Vaya J., Schipper H. M. 2007. Oxysterols, cholesterol homeostasis, and Alzheimer disease. J. Neurochem. 102: 1727\u20131737.", "ArticleIdList": ["17573819"]}, {"Citation": "Kha H. T., Basseri B., Shouhed D., Richardson J., Tetradis S., Hahn T. J., Parhami F. 2004. Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat. J. Bone Miner. Res. 19: 830\u2013840.", "ArticleIdList": ["15068507"]}, {"Citation": "Shouhed D., Kha H. T., Richardson J. A., Amantea C. M., Hahn T. J., Parhami F. 2005. Osteogenic oxysterols inhibit the adverse effects of oxidative stress on osteogenic differentiation of marrow stromal cells. J. Cell. Biochem. 95: 1276\u20131283.", "ArticleIdList": ["15880703"]}, {"Citation": "Liu H., Yuan L., Xu S., Wang K., Zhang T. 2005. Cholestane-3beta,5alpha,6beta-triol inhibits osteoblastic differentiation and promotes apoptosis of rat bone marrow stromal cells. J. Cell. Biochem. 96: 198\u2013208.", "ArticleIdList": ["16052487"]}, {"Citation": "Nicholls S. J., Hazen S. L. 2009. Myeloperoxidase, modified lipoproteins, and atherogenesis. J. Lipid Res. 50: S346\u2013S351.", "ArticleIdList": ["PMC2674690", "19091698"]}, {"Citation": "Maki R. A., Tyurin V. A., Lyon R. C., Hamilton R. L., DeKosky S. T., Kagan V. E., Reynolds W. F. 2009. Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease. J. Biol. Chem. 284: 3158\u20133169.", "ArticleIdList": ["PMC2631957", "19059911"]}]}], "History": [{"Year": "2010", "Month": "10", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "10", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "6", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2012", "Month": "1", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["20921334", "PMC2999934", "10.1194/jlr.M006775", "S0022-2275(20)40499-7"]}}], "PubmedBookArticle": []}